Cargando…
Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
Limited improvement in long term survival of lung cancer patients has been achieved by conventional chemotherapy or targeted therapy. To explore the potentials of tumor initiating cells (TIC)-directed therapy, it is essential to identify the cell targets and understand their maintenance mechanisms....
Autores principales: | Liu, Jing, Xiao, Zhijie, Wong, Sunny Kit-Man, Tin, Vicky Pui-Chi, Ho, Ka-Yan, Wang, Junwen, Sham, Mai-Har, Wong, Maria Pik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858556/ https://www.ncbi.nlm.nih.gov/pubmed/24091605 |
Ejemplares similares
-
HiC-DC+ enables systematic 3D interaction calls and differential analysis for Hi-C and HiChIP
por: Sahin, Merve, et al.
Publicado: (2021) -
HiChIPdb: a comprehensive database of HiChIP regulatory interactions
por: Zeng, Wanwen, et al.
Publicado: (2022) -
NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
por: Xiao, Zhi-Jie, et al.
Publicado: (2017) -
HiCUP: pipeline for mapping and processing Hi-C data
por: Wingett, Steven, et al.
Publicado: (2015) -
Loop detection using Hi-C data with HiCExplorer
por: Wolff, Joachim, et al.
Publicado: (2022)